Optimising quality of life and survival for brain cancer patients Australia-wide.
The Brain Cancer Biobanking Australia (BCBA) will establish a process for identifying and refining a set of clinical indicators to measure quality of care across the entire trajectory of the brain cancer patient journey.
The BCBA will convene a multi-disciplinary panel of brain cancer experts to prioritise and gain consensus on paediatric and adult quality care clinical benchmarks. The indicators developed will be used to build a national clinical registry. Once established, the data collected will guide clinicians, hospitals and other stakeholders in activities to reduce variations in care, ultimately optimising quality of life and survival for brain cancer patients Australia-wide.
Who is this project for?
- Brain cancer clinicians
- State & Federal Health Departments
- Peak bodies such as Cooperative Trials Group for Neuro-Oncology (COGNO), Australian and New Zealand Children’s Haematology/Oncology Group (ANZCHOG), Neurosurgical Society of Australasia (NSA)
What does this project enable?
This project will enable the relevant clinical stakeholders to reach consensus on the clinical quality indicators essential to guiding the collection of data for a clinical registry that ultimately will facilitate evaluations of the quality of care delivered to brain cancer patients across Australia.